Create Medicines
CM
CR
Create Medicines
Developing in vivo immunotherapies for autoimmune diseases and cancer.
About
Create Medicines is a biotechnology startup focused on developing in vivo immunotherapies. Their approach targets autoimmune diseases and cancer by leveraging the body's own immune system. The company has secured significant Series B funding to advance its research and development efforts.
Key facts
At-a-glance profile data
- Headquarters
- Cambridge, Massachusetts, USA
- Total funding
- $122M (Series B)
- Business model
- B2B
Add first review
Frequently asked
How much funding has Create Medicines raised?
Create Medicines has raised a total of $122M in funding. The most recent round on record is Series B.